Epidemiological and Clinical Insights into Pulmonary Tuberculosis among Diabetic Patients: A Descriptive Retrospective Study in N'Djamena, Chad

Ngakoutou Rangar

Department of Pulmonology, Reference Nationale University Hospital Center, N’Djamena, Chad.

Mahamat Ali Bolti *

Department of Medicine, Renaissance University Hospital Center, N’Djamena, Chad.

Ahmet Abdulaye

Department of Pulmonology, Reference Nationale University Hospital Center, N’Djamena, Chad.

Dieudonne Dlinga

Department of Pulmonology, Reference Nationale University Hospital Center, N’Djamena, Chad.

Yusra Aboulbachar

Department of Medicine, Renaissance University Hospital Center, N’Djamena, Chad.

Oumar Abba

Department of Pulmonology, Reference Nationale University Hospital Center, N’Djamena, Chad.

Choua Ouchemi

Faculty of Human Health Sciences in N’Djamena, N’Djamena University, Chad.

Ali Mahamat Moussa

Faculty of Human Health Sciences in N’Djamena, N’Djamena University, Chad.

*Author to whom correspondence should be addressed.


Introduction: association with HIV tuberculosis is a real public health problem according the International Union Against Tuberculosis and Lung Disease. The objective of this work is to study the epidemiological, progressive and therapeutic aspects of pulmonary tuberculosis in diabetic.

Methods: This is a descriptive retrospective study evaluating the association between pulmonary tuberculosis and diabetes in the pneumo-phtisiology department of the Reference National University Hospital Center over a period of 3 years about 51 cases.

Results: During our study period, we collected 51 cases of pulmonary tuberculosis and diabetes out of a total of all hospitalised patients. with a prevalence of Tuberculosis/Diabetes co-infection of 5.6%. The sex ratio was 2.18 in favour of men. The average age was 52.3 ±13.8 years with extrems ranging from 20 to 80 years old. The notion of tuberculosis infection was found in 21.6% of cases. Other comorbidities were present, such as hypertension (41.2%, n=21) and HIV (15.7%, n=8). The GenXpert results revealed MTB Detected in 62.7% of cases with 9 cases of Rifampicin Resistance Detected. The type of diabetes found was mainly Type 2 diabetes (88.2%) and the most common complication was diabetic foot. The treatment consisted of a quadruple therapy, Oral Antidiabetic (OAD) and insulin, or a combination of both.

Conclusion: This study shows that the association of tuberculosis and diabetes is a reality in our countries. The prevalence remains relatively high and the treatment regimen remains the same. Prevention of TB and correct management of diabetes could reduce the prevalence of this pandemic.

Keywords: Tuberculosis, diabetes, prevalence, N’Djamena, Chad

How to Cite

Rangar , Ngakoutou, Mahamat Ali Bolti, Ahmet Abdulaye, Dieudonne Dlinga, Yusra Aboulbachar, Oumar Abba, Choua Ouchemi, and Ali Mahamat Moussa. 2024. “Epidemiological and Clinical Insights into Pulmonary Tuberculosis Among Diabetic Patients: A Descriptive Retrospective Study in N’Djamena, Chad”. Asian Journal of Research in Infectious Diseases 15 (7):1-7. https://doi.org/10.9734/ajrid/2024/v15i7356.


Download data is not yet available.


Toujani S, Ben Salah N, Cherif J, Mjid M, Ouahchy Y, Zakhama H, et al. Primary infection and pulmonary tuberculosis. Rev Pneumol Clin. 2015;71(2):7382.

Wirth T, Hildebrand F, Allix-Bguec C, Wlbeling F, Kubica T, Kremer K, et al. Origin, Spread and Demography of the Mycobacterium tuberculosis Complex. PLOS Pathogens. 2008;4(9):e1000160.

Diarra B, Diallo A, Maiga M, Sanogo M, Diallo MH, Baya B, et al. Tuberculosis and diabetes in Bamako, Mali: Prevalence and epidemiological characteristics of the association. Rev Mal Infect Microbiol. 2014;24-6.

Djenebou T, Sylla SD, Djibril S, Massama K, Khadidia O, Noumou SD, et al. Tuberculosis among diabetics in Bamako. Health Sci Dis. 2020;21(11).

[Accessed on 31 Oct 2022].Available:http://hsd-fmsb.org/index.php/ hsd/article/view/2365

Morad S, Benjelloun H, Moubachir H, Zaghba N, Bakhatar A, Yassine N, et al. Clinical, radiological and progressive profile of pulmonary tuberculosis in diabetics. Rev Mal Respir. 2015;32: A225.

Toure N O, Dia Kane Y, Diatta A, Ba Diop S, Niang A, Ndiaye EM, et al. Tuberculosis and diabetes. Rev Mal Respir. 2007;24 (7):869-75.

Kouismi H, Hammi S, Bouti K, Rhanim A, Ataouna K, Razine R, et al. Pulmonary tuberculosis and diabetes mellitus profile. Integrative Journal of Medical Sciences. 2015;2(1).

Aynaou H, Latrech H. Cardiovascular comorbidity in hypertensive type 2 diabetic patients. Ann Endocrinol. 2014;75 (5):376.

World Health Organization. Global tuberculosis report 2013. World Health Organization. 2013;303.

Andrianiaina MMA, Raherison RE, Razanamparany T, Raharinavalona SA, Rakotomalala ADP, Andrianasolo RL .[Epidemiologic-clinical, biological and radiological characteristics of pulmonary tuberculosis in patients with diabetes in Antananarivo, Madagascar]. Pan Afr Med J. 2022;42:49.

Rhanim A, Zemed N, Marc K, Soualhi M, Zahraoui R, Benamor J, et al. Diabetes and pulmonary tuberculosis: Clinical, radiological and biological aspects. Rev Mal Respir. 2015;32:A224.

Tekpa G, Fikouma V, Tengothi RMM, Longo J de D, Woyengba APA, Koffi B. Epidemiological and clinical aspects of tuberculosis in hospitals in Bangui. Pan Afr Med J. 2019;33:31.

Diop SA, Massaly A, Ka D, Manga NM, Fortes-Dgunonvo L, Ndour CT, et al. Use of the genexpert test for the diagnosis of tuberculosis in the infectious diseases department of the Fann University Hospital. Pan Afr Med J. 2016;23(1). Available:https://www.ajol.info/index.php/pamj/article/view/139630

[Accessed on Dec 14, 2022].

15.Moustarhfir Elidrissi A, Benjelloun H, Zaghba N, Yassine N. Contribution of GeneXpert in the diagnosis of pulmonary tuberculosis. Rev Mal Respir. 2017;34:A215.

16. Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger CM, Schumacher SG, et al. Cochrane Database of Systematic Reviews 2018;(8).Available:https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012768.pub2/full

[Accessed on Dec 21, 2022].

Creswell J, Rai B, Wali R, Sudrungrot S, Adhikari LM, Pant R, et al. Introducing new tuberculosis diagnostics: The impact of Xpert MTB/RIF testing on case notifications in Nepal. Int J Tuberc Lung Dis. 2015;19(5):54551.

Okemba-Okombi FH, Itoua A, Biniakounou JB, Illoye-Ayet M, Bemba ELP, Ossal Abacka KB, et al. Contribution of GeneXpert in the diagnosis of pulmonary tuberculosis: Preliminary study and perspectives in the Republic of Congo. Rev Mal Respir. 2015;32:A211.

Toloba Y, Cisse AB, Soumare D, Ouattara K, Kanoute T, Kone D, et al. Contribution of GeneXpert in the diagnosis of tuberculosis and resistance to rifampicin in Mali after 22 months of acquisition. Rev Mal Respir. 2017;34:A216-7.

Mezghani S, Laadhar H, Hayouni A, Benzarti M, Jerray M. The association of pulmonary tuberculosis and diabetes mellitus. EM-Consult. 2008;20(HS1):153-66.

Maelej S, Belhaoui N, Bourguiba M, Mahouachi R, Chtourou A, Taktak S, et al. Pulmonary tuberculosis causes diabetes imbalance: Retrospective study of 60 patients in Tunisia. The Medical Press. 2009;38(1):20-4.

Sibomana T, Manirakiza M, Ndirahisha E, Mbonicura JC, Nkurunziza E, Ndikumwenayo F, et al. Epidemiological, clinical and radiological analyzes of the association of diabetes and pulmonary tuberculosis in a hospital environment in Bujumbura. Prospective study of 23 cases. Jaccr Infectiol. 2020;2(4):1-4.

Yan Lin, Anthony D Harries, Julia A Critchley, Philip Owiti, Anders Dejgaard, Ajay M V Kumar, et al. Diabetes-tuberculosis management: Guide to essential elements for good practice. Paris Bagsvaerd (Denmark): International Union against Tuberculosis and Lung Diseases World Diabetes Foundation; 2019;116.

Viswanathan V, Vigneswari A, Selvan K, Satyavani K, Rajeswari R, Kapur A. Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosisa report from South India. Journal of Diabetes and its Complications. 2014;28 (2):162-5.

Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W. Impact of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis. Am J Trop Med Hyg. 2009; 80(4):634-9.